ID26327A - Komposisi-komposisi turunan dari mycobacterium vaccae dan metoda untuk penggunaannya - Google Patents

Komposisi-komposisi turunan dari mycobacterium vaccae dan metoda untuk penggunaannya

Info

Publication number
ID26327A
ID26327A IDW20001433A ID20001433A ID26327A ID 26327 A ID26327 A ID 26327A ID W20001433 A IDW20001433 A ID W20001433A ID 20001433 A ID20001433 A ID 20001433A ID 26327 A ID26327 A ID 26327A
Authority
ID
Indonesia
Prior art keywords
methods
mycobacterium vaccae
low composition
composition
low
Prior art date
Application number
IDW20001433A
Other languages
English (en)
Inventor
Tan Paul
Watson James
Elizabeth S Visser
Margot A Skinner
Ross L Prestidge
Original Assignee
Genesis Res & Dev Corp Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/997,080 external-priority patent/US5968524A/en
Priority claimed from US08/997,362 external-priority patent/US5985287A/en
Priority claimed from US09/095,855 external-priority patent/US6160093A/en
Priority claimed from US09/205,426 external-priority patent/US6406704B1/en
Application filed by Genesis Res & Dev Corp Ltd filed Critical Genesis Res & Dev Corp Ltd
Publication of ID26327A publication Critical patent/ID26327A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
IDW20001433A 1997-12-23 1998-12-23 Komposisi-komposisi turunan dari mycobacterium vaccae dan metoda untuk penggunaannya ID26327A (id)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US99662497A 1997-12-23 1997-12-23
US08/997,080 US5968524A (en) 1997-12-23 1997-12-23 Methods and compounds for the treatment of immunologically-mediated psoriasis
US08/997,362 US5985287A (en) 1996-08-29 1997-12-23 Compounds and methods for treatment and diagnosis of mycobacterial infections
US09/095,855 US6160093A (en) 1996-08-29 1998-06-11 Compounds and methods for treatment and diagnosis of mycobacterial infections
US15618198A 1998-09-17 1998-09-17
US09/205,426 US6406704B1 (en) 1996-08-29 1998-12-04 Compounds and methods for treatment and diagnosis of mycobacterial infections

Publications (1)

Publication Number Publication Date
ID26327A true ID26327A (id) 2000-12-14

Family

ID=27557521

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20001433A ID26327A (id) 1997-12-23 1998-12-23 Komposisi-komposisi turunan dari mycobacterium vaccae dan metoda untuk penggunaannya

Country Status (15)

Country Link
EP (1) EP1044273A2 (id)
JP (1) JP2002514385A (id)
CN (1) CN1294632A (id)
AU (1) AU746311B2 (id)
BR (1) BR9814432A (id)
CA (1) CA2315539A1 (id)
HU (1) HUP0100352A2 (id)
ID (1) ID26327A (id)
IL (1) IL136821A0 (id)
MX (1) MXPA00006168A (id)
NO (1) NO20003261L (id)
NZ (1) NZ505834A (id)
PL (1) PL341697A1 (id)
TR (1) TR200001948T2 (id)
WO (1) WO1999032634A2 (id)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6569436B1 (en) 1998-10-05 2003-05-27 The Malaghan Institute Of Medical Research Method of using a vaccine
JP4415200B2 (ja) * 1999-01-29 2010-02-17 大塚製薬株式会社 遅発育性抗酸菌ポリペプチド
GB9903539D0 (en) 1999-02-16 1999-04-07 Stanford Rook Ltd Therapy using M.Vaccae
US6462669B1 (en) 1999-04-06 2002-10-08 E. P . Survivors Llc Replaceable LED modules
US6350457B1 (en) * 1999-06-02 2002-02-26 Genesis Research & Development Corporation Limited Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae
AU784847B2 (en) * 1999-07-12 2006-07-06 Genesis Research And Development Corporation Limited Compounds for treatment of infectious and immune system disorders and methods for their use
EP1208207A2 (de) * 1999-08-31 2002-05-29 Michael Niederweis Verfahren zur herstellung eines kanalbildenden proteins
NZ517409A (en) 1999-08-31 2004-05-28 Novozymes As RP-II properties with amino acid substitutions used in detergent compositions and additives
US7217554B2 (en) 1999-08-31 2007-05-15 Novozymes A/S Proteases and variants thereof
US6361776B1 (en) * 1999-12-06 2002-03-26 Genesis Research & Development Corp. Ltd. Compounds isolated from M. vaccae and their use in modulation of immune responses
US20030108527A1 (en) * 1999-12-28 2003-06-12 Tsukasa Seya Maturation-promoting agent for immature dendrtic cells
AUPQ761200A0 (en) * 2000-05-19 2000-06-15 Hunter Immunology Limited Compositions and methods for treatment of mucosal infections
US20030104012A1 (en) * 2001-05-11 2003-06-05 Corixa Corporation Vaccines for the treatment of autoimmune disease
US20030147861A1 (en) * 2001-07-26 2003-08-07 Genesis Research And Development Corporation Limited Compounds and methods for the modulation of immune responses
AU2002353366A1 (en) * 2001-12-10 2003-06-23 Bakulesh Mafatlal Khamar The process of manufacturing a pharmaceutical composition useful for management of cancer
GB0303507D0 (en) * 2003-02-14 2003-03-19 Novartis Ag Organic compounds
US10765731B2 (en) * 2014-01-09 2020-09-08 Transgene Sa Fusion of heterooligomeric mycobacterial antigens
CN115804834B (zh) * 2021-08-10 2025-10-21 昆明医科大学 一种具有提高免疫力和抗肿瘤以及延长寿命的多肽及其应用
CN119162167B (zh) * 2024-11-21 2025-03-11 四川大学华西医院 一种分枝杆菌基因组的提取方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8919321D0 (en) * 1989-08-25 1989-10-11 Univ London Treatment of chronic inflammatory conditions
GB9203814D0 (en) * 1992-02-21 1992-04-08 Univ London Treatment of long term auto-immune conditions
US6284255B1 (en) * 1996-08-29 2001-09-04 Genesis Research & Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections

Also Published As

Publication number Publication date
IL136821A0 (en) 2001-06-14
CN1294632A (zh) 2001-05-09
AU746311B2 (en) 2002-04-18
HUP0100352A2 (hu) 2001-06-28
WO1999032634A3 (en) 1999-12-02
TR200001948T2 (tr) 2001-02-21
JP2002514385A (ja) 2002-05-21
CA2315539A1 (en) 1999-07-01
BR9814432A (pt) 2000-10-10
WO1999032634A2 (en) 1999-07-01
MXPA00006168A (es) 2005-02-24
NO20003261D0 (no) 2000-06-22
NO20003261L (no) 2000-08-22
NZ505834A (en) 2002-12-20
PL341697A1 (en) 2001-04-23
EP1044273A2 (en) 2000-10-18
AU1893699A (en) 1999-07-12

Similar Documents

Publication Publication Date Title
ID22889A (id) Komposisi kopolimer etilena dan penggunaannya
ID27922A (id) KOMPOSISI FARMASETIKAL DAN PENGGUNAAN DARI ANDROST-5-ENA-3β, 17β-DIOL
DE69707998D1 (de) Befestigungsmittelstreifen und Klebstoffzusammensetzung
ID26964A (id) Komposisi dan metode untuk pengaturan pengaktifan limfosit
ID24196A (id) Komposisi dan penggunaan
ID22957A (id) Senyawa dan penggunaannya
DE69831755D1 (de) Optoakustische kontrastmittel und anwendungsverfahren
ID21859A (id) Bahan lembaran serupa-kulit dan metode untuk memproduksi bahan tersebut
FR2781666B1 (fr) Composition cosmetique solide et ses utilisations
BR9702553A (pt) Composição cosmética e utilização
ID23575A (id) Pirazolopirimidina-pirazolopirimidina dan pirazolotriazina-pirazolotriazina
ID27667A (id) Komposisi coklat dan pemakaiannya
ID28728A (id) Komposisi dan proses pengkrepan
ID24470A (id) Komposisi pewarna rambut dan penggunaannya
ID23985A (id) Baterai dan metode pembuatannya
DE69723398D1 (de) Polyalkylphenoxyaminoalkane und diese enthaltende freibstoffzusammensetzungen
IL132146A0 (en) Composition for the detection of electrophilic gases and methods of use thereof
DE69712962D1 (de) Styrol-Butadien-Copolymer und dieses Copolymer enthaltende Gummimischung
ID16889A (id) Senyawa turunan alkilaminobenzotiazol dan benzoksazol
ATE274024T1 (de) Sauerstoffabsorbierende zusammensetzung und ihre anwendungsmethode
PL341697A1 (en) Compositions derived from mycobacterium vaccae and methods of using them
ID17199A (id) Mikro-organisme pengurai hidrokarbon yang mengandung halogen dan pemakaiannya
ID23258A (id) Penarik pemberian-menyilang dan metodenya
ID20056A (id) Minyak pelumas, komposisi minyak pelumas dan komposisi bahan bakar minyak
ID16587A (id) Koproduksi 6-aminokapronitril dan heksametilendiamin